Baseline characteristics | Incident dialysisa (n = 338) | Prevalent PD (n = 62) | p | |
---|---|---|---|---|
Age (years; n = 338/62) | 63 (45–80) | 65 (49–81) | NS | |
Female (%; n = 338/62) | 105 (31) | 23 (35) | NS | |
CVD (%; n = 336/62) | 177(53) | 19 (31) | 0.001 | |
DM (%; n = 338/62) | 84 (25) | 13 (21) | NS | |
Davies Comorbidity Score (%; n = 335/62) | Low risk (0) | 124 (37) | 19 (31) | NS |
Medium risk (1–2) | 150 (45) | 34 (55) | ||
High risk (≥3) | 61 (18) | 9 (15) | ||
BMI (kg/m2; n = 338/62) | 25 (22–28) | 25 (23–28) | NS | |
MBP (mmHg, n = 333/62) | 103 (85–126) | 97.0 (80–117) | 0.0004 | |
eGFRb(ml/min, n = 338/62) | 4.9 (2.9–9.6) | 5.8 (4.5–9.2) | 0.0004 | |
Weekly KT/V (renal + peritoneal) | NA | 2.2(1.7–2.9) | – | |
Metabolic biomarkers | ||||
Hemoglobin (g/L, n = 338/62) | 109 (89–127) | 121 (106–132) | < 0.0001 | |
Albumin (g/L; n = 336/62) | 32 (25–39) | 32 (24.6–38) | NS | |
Potassium (mmol/L, n = 338/62) | 4.4 (3.5–5.4) | 4.1 (3.2–4.9) | 0.0002 | |
Ca x P (n = 337/62) | 4.5 (2.8–6.5) | 3.9 (2.6–5.5) | < 0.0001 | |
PTH (ng/L, n = 327/62) | 200 (45–595) | 256 (78–567) | 0.03 | |
CRP (mg/L; n = 333/62) | 8(5.1–75.6) | 4.1(0.7–26.2) | 0.002 | |
IL-6 (pg/mL; n = 147/62) | 5.6 (2.1–29.0)c | 6.4 (2.1–21.7) | NS |